newsfilter
← Latest News
PR Newswire·

Miravo Healthcare™ Announces First Quarter 2021 Results

- Q1 2021 Adjusted Total Revenue - $14.5 million -- Q1 2021 Adjusted EBITDA - $4.4 million -- Blexten Canadian Prescriptions Increased 22% Year-Over-Year -- Cambia Canadian Prescriptions Increased 9% Year-Over-Year - Miravo to Hold Virtual Annual M